Effects of antithrombotic drugs on thrombosis and bleeding risk in patients undergoing thoracic surgery

Conditions

None listed

Brief summary

Drug withdrawal in the preoperative period may give rise to the risks, such as rebound phenomenon or thrombosis. Our aim is to determine the incidence of thrombotic complications that may be associated with discontinuation of preoperative anticoagulants in patients undergoing thoracic surgery.

Related papers

No related papers found yet.

Interventions

A total of 100 patients over 18 years of age who had undergone thoracic surgery were included in the study. Only if the patient has had more than one surgery, only the data of the first surgery will be included in the study. Demographic data, cardiac reserves, preoperative and postoperative hemogram values, frequency of anticoagulant drug use, duration and type of drug, transfusion amount of blood and blood products, complications and mortality rates were recorded during surgery. In addition, ot

A total of 100 patients over 18 years of age who had undergone thoracic surgery were included in the study. Only if the patient has had more than one surgery, only the data of the first surgery will be included in the study. Demographic data, cardiac reserves, preoperative and postoperative hemogram values, frequency of anticoagulant drug use, duration and type of drug, transfusion amount of blood and blood products, complications and mortality rates were recorded during surgery. In addition, other laboratory tests, type of surgery, frequency of re-exploration, duration of intensive care and hospital stay and causes of death were recorded first 48 hours after surgery.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Healthy volunteers

No

Inclusion criteria

Cardiac patients over 18 years of age who will undergo open thoracic surgery or thoracoscopy and who use anticoagulants will be included in the study.

Exclusion criteria

Patients with emergency surgery, patients under 18 years of age, patients with known bleeding disorder, patients with renal insufficiency, hepatic failure or congestive heart failure will be excluded from the study.

Outcome results